Cargando…
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin
The transient precorneal retention time and low penetration capacity into intraocular tissues are the key obstacles that hinder the ophthalmic drug delivery of many therapeutic compounds, especially for drugs with poor solubility and permeability. To break the stalemate, N-acetyl-L-cysteine function...
Autores principales: | Liu, Dandan, Li, Jinyu, Pan, Hao, He, Fengwei, Liu, Zhidong, Wu, Qingyin, Bai, Chunping, Yu, Shihui, Yang, Xinggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923878/ https://www.ncbi.nlm.nih.gov/pubmed/27350323 http://dx.doi.org/10.1038/srep28796 |
Ejemplares similares
-
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions
por: Zhang, Wenji, et al.
Publicado: (2014) -
A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform
por: Yu, Yibin, et al.
Publicado: (2019) -
Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use
por: L. Kiss, Eszter, et al.
Publicado: (2019) -
Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier
por: Sun, Mingshuang, et al.
Publicado: (2017) -
In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration
por: Fang, Min, et al.
Publicado: (2012)